Physician profile
Daniel Gomez
NPI 1225323678
$310,717.08
in general payments reported to CMS, 2019-2025
33 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $43K · 2021: $49K · 2022: $68K · 2023: $46K · 2024: $46K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $83K · Travel and Lodging: $14K · Consulting Fee: $9,163 · Food and Beverage: $2,877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $83,000.00 |
| Travel and Lodging | $14,202.93 |
| Consulting Fee | $9,162.50 |
| Food and Beverage | $2,877.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $276,504.96 | 2019-2025 | Gelpoint V-Path |
| Teleflex LLC | $12,113.24 | 2019-2021 | |
| Momentis Surgical INC. | $10,829.40 | 2021-2023 | Anovo Surgical System |
| Distalmotion US | $6,507.81 | 2024-2025 | Dexter L6 Robot |
| Scynexis, INC. | $1,151.16 | 2022 | |
| Coopersurgical, INC. | $783.61 | 2019-2023 | Paragard T 380a |
| Intuitive Surgical, INC. | $762.08 | 2022-2024 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $276.05 | 2020-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Conmed Corporation | $237.04 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $234.52 | 2022-2025 | |
| Astellas Pharma US INC | $208.31 | 2023-2025 | Veozah |
| Medical Device Business Services, INC. | $124.99 | 2023 | Enseal |
| Aspira Women'S Health INC | $108.43 | 2023 | Ova1 |
| Boston Scientific Corporation | $93.12 | 2025 | General - Therapies |
| Millicent US INC | $88.23 | 2024-2025 | Intrarosa, Femlyv, Femring |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $71.43 | 2022-2024 | |
| Asensus Surgical, INC. | $67.44 | 2019 | |
| Organon LLC | $66.19 | 2023-2024 | |
| Meditrina | $61.38 | 2024 | |
| Avanos Medical | $55.97 | 2020-2021 | |
| Exeltis, USA INC. | $47.71 | 2024-2025 | Slynd |
| Novo Nordisk INC | $43.04 | 2024-2025 | Wegovy |
| Baxter Healthcare | $40.38 | 2019-2025 | Perclot |
| Biogen, INC. | $39.66 | 2024-2025 | Zurzuvae |
| Lilly USA, LLC | $36.97 | 2025 | Zepbound |
| Biotissue Holdings INC. | $35.57 | 2025 | |
| Shield Therapeutics INC | $32.56 | 2024 | |
| Agile Therapeutics, INC. | $27.04 | 2023-2024 | Twirla |
| Pfizer INC. | $19.56 | 2024 | |
| Mimedx Group, INC. | $14.83 | 2025 | |
| Abbvie INC. | $13.71 | 2023 | |
| Abbott Laboratories | $13.14 | 2020 | |
| Channel Medsystems, INC. | $7.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.